It offers the flexibility lacking in some treatments: you can take it anytime, with or without food
The new treatment a once-weekly injectable from Novo Nordisk, a Danish pharmaceutical company that has hired many leading diabetes and obesity scientists as consultants is poised to safely help many people with health-threatening obesity, physicians and researchers say
Stimulation of these receptors could theoretically increase sympathetic outflow, leading to a mild chronotropic (heart rate-increasing) effect
Medullary Thyroid Cancer (MTC) During early laboratory studies, researchers found that GLP-1 medications caused an increase in C-cell tumours and medullary thyroid cancer (MTC) in rats and mice
The supplement and medication markets are flooded with GLP-1 medications and supplements
This component may already be in your routine, eliminating additional cost